JMPWA
RNAM

JP Morgan Private Wealth Advisors’s Avidity Biosciences RNAM Stock Holding History

JP Morgan Private Wealth Advisors’s Portfolio RNAM Stock Details RNAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-18,900
Closed -$412K – 1935
2021
Q1 		$412K Hold
18,900
– – ﹤0.01% 1397
2020
Q4 		$482K Buy
+18,900
New +$551K ﹤0.01% 1305

Other funds holding RNAM

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return

JP Morgan Private Wealth Advisors's RNAM Position: Q2 2021 in Review

JP Morgan Private Wealth Advisors sold out of Avidity Biosciences (RNAM) in Q2 2021, closing a stake of 18,900 shares — an estimated $412K sold.

JP Morgan Private Wealth Advisors first reported a position in RNAM in Q4 2020 and held it in 2 quarters. The position peaked at $482K in Q4 2020. 95 funds tracked by Wall St. Rank hold RNAM as of Q2 2021.

  • JP Morgan Private Wealth Advisors reported no remaining Avidity Biosciences position as of Q2 2021 after selling out during the quarter.
  • JP Morgan Private Wealth Advisors sold 18,900 Avidity Biosciences shares in Q2 2021, an estimated $412K.
  • JP Morgan Private Wealth Advisors first reported a position in Avidity Biosciences in Q4 2020 and held it in 2 quarters.
  • JP Morgan Private Wealth Advisors's Avidity Biosciences position peaked at $482K in Q4 2020.
  • 95 funds tracked by Wall St. Rank held Avidity Biosciences as of Q2 2021.

Based on JP Morgan Private Wealth Advisors's 13F filing for Q2 2021, filed 16 Aug 2021.